Table of Contents
ISRN Spectroscopy
Volume 2014, Article ID 541970, 7 pages
Research Article

Novel Spectrophotometric Methods for the Determination of Selegiline Hydrochloride in Bulk and Its Pharmaceutical Preparation

Department of Post-Graduate Studies and Research in Chemistry, Mangalore University, Mangalagangothri 574199, India

Received 27 November 2013; Accepted 18 January 2014; Published 23 February 2014

Academic Editors: Y. C. Ling and T. Strunskus

Copyright © 2014 Kumble Divya and Badiadka Narayana. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Birkmayer, J. Knoll, P. Riederer, and M. B. Youdim, “(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease,” Modern problems of pharmacopsychiatry, vol. 19, pp. 170–176, 1983. View at Google Scholar · View at Scopus
  2. A. Clarke, F. Brewer, E. S. Johnson et al., “A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition,” Journal of Neural Transmission, vol. 110, no. 11, pp. 1241–1255, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Birks and L. Flicker, “Selegiline for Alzheimer's disease,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD00044, 2003. View at Google Scholar · View at Scopus
  4. H. Allain, J. Cougnard, and H.-C. Neukirch, “Selegiline in de novo parkinsonian patients: the French selegiline multicenter trial (FSMT),” Acta Neurologica Scandinavica, Supplement, vol. 84, no. 136, pp. 73–78, 1991. View at Google Scholar · View at Scopus
  5. J. D. Amsterdam, “A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder,” Journal of Clinical Psychiatry, vol. 64, no. 2, pp. 208–214, 2003. View at Google Scholar · View at Scopus
  6. B. G. Katzung, Basic & Clinical Pharmacology, Lange Medical Books, McGraw-Hill, New York, NY, USA, 9th edition, 2004.
  7. J. A. Braddock, D. B. Church, I. D. Robertson, and A. D. J. Watson, “Inefficacy of selegiline in treatment of canine pituitary-dependent hyper-adrenocorticism,” Australian Veterinary Journal, vol. 82, no. 5, pp. 272–277, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Pichini, R. Pacifici, M. Pellegrini et al., “Development and validation of a high-performance liquid chromatography—mass spectrometry assay for determination of amphetamine, methamphetamine, and methylenedioxy derivatives in meconium,” Analytical Chemistry, vol. 76, no. 7, pp. 2124–2132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Nishida, S. Itoh, N. Inoue, K. Kudo, and N. Ikeda, “High-performance liquid chromatographic-mass spectrometric determination of methamphetamine and amphetamine enantiomers, desmethylselegiline and selegiline, in hair samples of long-term methamphetamine abusers or selegiline users,” Journal of Analytical Toxicology, vol. 30, no. 4, pp. 232–237, 2006. View at Google Scholar · View at Scopus
  10. M. H. Slawson, J. L. Taccogno, R. L. Foltz, and D. E. Moody, “Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry,” Journal of Analytical Toxicology, vol. 26, no. 7, pp. 430–437, 2002. View at Google Scholar · View at Scopus
  11. R. La Croix, E. Pianezzola, and M. S. Benedetti, “Sensitive high-performance liquid chromatographic method for the determination of the three main metabolites of selegiline (L-deprenyl) in human plasma,” Journal of Chromatography B, vol. 656, no. 1, pp. 251–258, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Katagi, M. Tatsuno, A. Miki, M. Nishikawa, K. Nakajima, and H. Tsuchihashi, “Simultaneous determination of selegiline-N-oxide, a new indicator for selegiline administration, and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry,” Journal of Chromatography B, vol. 759, no. 1, pp. 125–133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Szebeni, J. Lengyel, G. Szekacs, K. Magyar, J. Gaal, and I. Szatmari, “Gas chromatographic procedure for simultaneous determination of selegiline metabolites, amphetamine, methamphetamine and demethyl-deprenyl in pig plasma,” Acta Physiologica Hungarica, vol. 83, no. 2, pp. 135–141, 1995. View at Google Scholar · View at Scopus
  14. K. S. Patrick, B. Lan Nguyen, and J. D. McCallister, “Gas chromatographic-mass spectrometric determination of plasma selegiline using a deuterated internal standard,” Journal of Chromatography, vol. 583, no. 2, pp. 254–258, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. H. H. Maurer and T. Kraemer, “Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abuse of methamphetamine or amphetamine,” Archives of Toxicology, vol. 66, no. 9, pp. 675–678, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Netriová, J. Sádecká, and I. Skačáni, “Spectrofluorimetric determination of selegiline,” Farmaceuticky Obzor, vol. 74, no. 7, pp. 181–186, 2005. View at Google Scholar · View at Scopus
  17. M. Hasegawa, K. Matsubara, S. Fukushima, C. Maseda, T. Uezono, and K. Kimura, “Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy,” Forensic Science International, vol. 101, no. 2, pp. 95–106, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. G. Vijaya, Y. Triveni, K. Divya, N. K. Lakshmi, and G. G. Venu, “Application of MBTH and sulphanilic acid for the quantitative spectrophotometric determination of diacerein in bulk and formulations,” Der Pharma Chemica, vol. 1, no. 2, pp. 285–229, 2009. View at Google Scholar
  19. E. Sawicki, T. W. Stanley, T. R. Hauser, W. Elbert, and J. L. Noe, “Spot test detection and colorimetric determination of aromatic amines and imino heteroaromatic compounds with 3-methyl-2-benzothiazolone hydrazone,” Analytical Chemistry, vol. 33, no. 6, pp. 722–725, 1961. View at Google Scholar · View at Scopus
  20. N. Theia Al-Sabha, “Spectrophotometric assay of phenylephrine hydrochloride using 4-aminoantipyrine and copper (II),” Pakistan Journal of Analytical and Environmental Chemistry, vol. 11, no. 1, pp. 01–07, 2010. View at Google Scholar
  21. International Conference on Harmonization (ICH) Guidelines,
  22. G. D. Christian and J. E. O'Rilly, “Jobs method,” in Instrumental Analysis, Prentice Hall, Upper Saddle River, NJ, USA, 2nd edition, 1980. View at Google Scholar